---
title: 'Multi-Modal Omics & Radiomics Pipelines: From Raw Medical Data to Predictive RWE Models'
description: Transforming high-dimensional medical imaging and multi-omics data into validated Real-World Evidence models.
publishedTime: '2026-09-02'
---

<p class="post-kicker">Healthcare AI · Radiomics · Real-world evidence</p>

![Multi-modal fusion of radiomics, genomics and AI pipelines](/img/assets/post_omics_radiomics/omics-radiomics-hero.jpg)

*Multi-modal data fusion: imaging + omics → predictive RWE models*

Quantitative medical imaging and molecular datasets contain dense, sub-visual biological signals capable of predicting therapeutic response, gene mutations, and overall survival in oncology. Transforming these high-dimensional, unstructured datasets into validated, production-grade Real-World Evidence (RWE) models requires rigorous data engineering, standardized feature extraction, and privacy-first machine learning architectures.

## The Technical Challenge

Building clinical-grade predictive models from medical imaging and multi-omics data presents several critical engineering hurdles:

- **Scanner & Center Heterogeneity:** Variations in scanner hardware, acquisition protocols, and reconstruction parameters introduce severe batch effects and non-biological noise across datasets.
- **High-Dimensionality ("Curse of Dimensionality"):** Automated feature extraction generates thousands of candidate variables (intensity, shape, texture, deep network embeddings) relative to limited patient cohorts, requiring strict feature selection to prevent overfitting.
- **Data Silos & Privacy Constraints:** Strict data protection regulations prevent centralized pooling of sensitive clinical images and electronic health records (EHR) across multicenter research networks.

## Modus Data Engineering Capabilities

At **Modus Data**, we design and deploy scalable data architectures, feature extraction pipelines, and machine learning models tailored for complex biomedical applications. Our expertise bridges raw clinical data and actionable predictive insights:

### 1. End-to-End Feature Extraction Pipelines

- **Automated Image Pre-Processing:** Standardized 3D/4D workflows for image resampling, intensity normalization, voxel filtering, and noise reduction.
- **IBSI-Compliant Extraction:** Automated extraction of handcrafted radiomic features (first-order statistics, GLCM, GLRLM, NGTDM texture matrices, and wavelet transforms) fully aligned with Image Biomarker Standardization Initiative (IBSI) guidelines.
- **Deep Feature Engineering:** Leveraging Convolutional Neural Networks (CNNs) and vision models to extract abstract spatial features directly from region-of-interest (ROI) volumes.

![Radiomics and multi-omics feature extraction and fusion pipeline](/img/assets/post_omics_radiomics/omics-radiomics-pipeline.jpg)

*End-to-end radiomics + multi-modal fusion pipeline*

### 2. Feature Selection & Robustness Modeling

- **Multi-Stage Feature Reduction:** Robust pipeline integration utilizing test-retest stability screening, variance filtering, and embedded regularization methods (e.g., LASSO, Elastic Net, Random Forests).
- **Harmonization & Batch Correction:** Implementation of domain-harmonization algorithms to remove inter-scanner variability, ensuring model generalizability across independent external validation cohorts.

### 3. Multi-Modal "Medomics" Fusion

- **Data Integration Architectures:** Harmonizing structural imaging (CT, MRI) and functional imaging (PET, DECT) with clinical covariates, genomic mutations (e.g., EGFR, ALK, PD-L1), and longitudinal EHR data.
- **Predictive Risk Scoring:** Constructing unified ML/DL models and nomograms to evaluate treatment susceptibility (immunotherapy, targeted therapies) and long-term clinical outcomes.

### 4. Privacy-Preserving Federated Learning

- **Distributed AI Infrastructure:** Deploying federated learning frameworks that enable multi-institutional model training without sensitive patient data ever leaving local hospital firewalls.

![Privacy-preserving federated learning across hospitals](/img/assets/post_omics_radiomics/omics-radiomics-federated.jpg)

*Federated learning: models travel, data stays local*

## Real-World Impact

By formalizing complex biomedical data into reproducible engineering pipelines, Modus Data enables pharmaceutical, biotech, and digital health organizations to:

- Identify non-invasive digital biomarkers from routine standard-of-care imaging.
- Accelerate real-world evidence (RWE) generation for clinical trial design and post-market surveillance.
- Transition complex machine learning research into validated, enterprise-ready software platforms.

## Partner with Modus Data

Looking to build, scale, or validate multi-modal AI and omics pipelines for your healthtech platform or clinical studies? [Contact Modus Data to discuss your architecture](https://modusdata.ch/contact).
